The effects of fasudil on the permeability of the rat blood-brain barrier and blood-spinal cord barrier following experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 239, Issue 1-2, 2011, Pages 61-67

  Huang, X N ^a   Fu, J ^a   Wang, W Z ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Blood spinal cord barrier; Experimental autoimmune encephalomyelitis; Fasudil; Multiple sclerosis

Indexed keywords

EVANS BLUE; FASUDIL; MESSENGER RNA; MYELIN; MYOSIN LIGHT CHAIN; OCCLUDIN; PROTEIN ROCK2; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SPINAL CORD BARRIER; CEREBELLUM; CONTROLLED STUDY; DEMYELINATION; DISEASE MODEL; DRUG EFFECT; EXTRAVASATION; FEMALE; GENE EXPRESSION; GUINEA PIG; INFLAMMATORY INFILTRATE; LUMBAR ENLARGEMENT; LUMBAR SPINE; MULTIPLE SCLEROSIS; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SPINAL CORD;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; BLOOD-BRAIN BARRIER; CELL MEMBRANE PERMEABILITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; ISOENZYMES; MEMBRANE PROTEINS; MULTIPLE SCLEROSIS; PILOT PROJECTS; PROTEIN KINASE INHIBITORS; RANDOM ALLOCATION; RATS; RATS, INBRED LEW; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 80054953599     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.08.015     Document Type: Article

References (55)

1. Agrawal S.M., Yong V.W. Immunopathogenesis of multiple sclerosis. Int. Rev. Neurobiol. 2007, 79:99-126.
2. Ahn B.J., Lee H.J., Shin M.W., Choi J.H., Jeong J.W., Kim K.W. Ninjurin1 is expressed in myeloid cells and mediates endothelium adhesion in the brains of EAE rats. Biochem. Biophys. Res. Commun. 2009, 387(2):321-325. 18.
3. Alvarez J.I., Cayrol R., Prat A. Disruption of central nervous system barriers in multiple sclerosis. Biochim. Biophys. Acta 2010, 10.1016/j.bbadis.2010.06.017.
4. Amano M., Chihara K., Kimura K., Fukata Y., Nakamura N., Matsuura Y., Kaibuchi K. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 1997, 275:1308-1311.
5. Balda M.S., Whitney J.A., Flores C., Gonzalez S., Cereijido M., Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J. Cell Biol. 1996, 134:1031-1049.
6. Ballabh P., Braun A., Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 2004, 16:1-13.
7. Bauer A.T., Burgers H.F., Rabie T., Marti H.H. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J. Cereb. Blood Flow Metab. 2009, 30:837-848.
8. Bennett J., Kollar A., Biron K.E., Reickmann P., Jefferies W.A., McQuaid S. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE. J. Neuroimmunol. 2010, 10.1016/j.jneuroim.2010.08.011.
9. Brini E., Ruffini F., Bergami A., Brambilla E., Dati G., Greco B., Cirillo R., Proudfoot A.E., Comi G., Furlan R., Zaratin P., Martino G. Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss. J. Neuroimmunol. 2009, 209(1-2):33-39. 30.
10. Bruewer M., Hopkins A.M., Hobert M.E., Nusrat A., Madara J.L. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin. Am. J. Physiol. Cell Physiol. 2004, 287:C327-C335.
11. Chen Y., Merzdorf C., Paul D.L., Goodenough D.A. COOH terminus of occludin is required for tight junction barrier function in early Xenopus embryos. J. Cell Biol. 1997, 138:891-899.
12. Deng L., Li G., Li R., Liu Q., He Q., Zhang J. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo. Cancer Biol. Ther. 2010, 9:875-884.
13. Engelhardt B., Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005, 26:485-495.
14. Fabis M.J., Scott G.S., Kean R.B., Koprowski H., Hooper D.C. Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:5656-5661.
15. Fan L., Sebe A., Peterfi Z., Masszi A., Thirone A.C., Rotstein O.D., Nakano H., McCulloch C.A., Szaszi K., Mucsi I., Kapus A. Cell contact-dependent regulation of epithelial-myofibroblast transition via the Rho-Rho kinase-phospho-myosin pathway. Mol. Biol. Cell 2007, 18:1083-1097.
16. Hawkins B.T., Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 2005, 57:173-185.
17. Jou T.S., Schneeberger E.E., Nelson W.J. Structural and functional regulation of tight junctions by RhoA and Rac1 small GTPases. J. Cell Biol. 1998, 142:101-115.
18. Kirk J., Plumb J., Mirakhur M., McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J. Pathol. 2003, 201:319-327.
19. Leech S., Kirk J., Plumb J., McQuaid S. Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol. Appl. Neurobiol. 2007, 33:86-98.
20. Lees J.R., Archambault A.S., Russell J.H. T-cell trafficking competence is required for CNS invasion. J. Neuroimmunol. 2006, 177(1-2):1-10.
21. Leung T., Chen X.Q., Manser E., Lim L. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol. Cell. Biol. 1996, 16:5313-5327.
22. Luccarini I., Ballerini C., Biagioli T., Biamonte F., Bellucci A., Rosi M.C., Grossi C., Massacesi L., Casamenti F. Combined treatment with atorvastatin and minocycline suppresses severity of EAE. Exp. Neurol. 2008, 211:214-226.
23. Man S., Ubogu E.E., Ransohoff R.M. Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol. 2007, 17:243-250.
24. Matter K., Balda M.S. Holey barrier: claudins and the regulation of brain endothelial permeability. J. Cell Biol. 2003, 161:459-460.
25. Miyamoto K., Nagaosa N., Motoyama M., Kataoka K., Kusunoki S. Upregulation of water channel aquaporin-4 in experimental autoimmune encephalomyelitis. J. Neurol. Sci. 2009, 276:103-107.
26. Morgan L., Shah B., Rivers L.E., Barden L., Groom A.J., Chung R., Higazi D., Desmond H., Smith T., Staddon J.M. Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis. Neuroscience 2007, 147:664-673.
27. Mueller B.K., Mack H., Teusch N. Rho kinase, a promising drug target for neurological disorders. Nat. Rev. Drug Discov. 2005, 4:387-398.
28. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 2003, 161:653-660.
29. Padden M., Leech S., Craig B., Kirk J., Brankin B., McQuaid S. Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology. Acta Neuropathol. 2007, 113:177-186.
30. Paintlia A.S., Paintlia M.K., Singh A.K., Singh I. Inhibition of Rho family functions by lovastatin promotes myelin repair in ameliorating experimental autoimmune encephalomyelitis. Mol. Pharmacol. 2008, 73:1381-1393.
31. Paris L., Tonutti L., Vannini C., Bazzoni G. Structural organization of the tight junctions. Biochim. Biophys. Acta. 2008, 646-659.
32. Persidsky Y., Ramirez S.H., Haorah J., Kanmogne G.D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol. 2006, 1:223-236.
33. Peruga I., Hartwig S., Thöne J., Hovemann B., Gold R., Juckel G., Linker R.A. Inflammation modulates anxiety in an animal model of multiple sclerosis. Behav. Brain Res. 2011, 220(1):20-29. 20.
34. Plumb J., McQuaid S., Mirakhur M., Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 2002, 12:154-169.
35. Pozza M., Bettelli C., Aloe L., Giardino L., Calza L. Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution. Brain Res. 2000, 855:39-46.
36. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 2003, 3:569-581.
37. Reijerkerk A., Kooij G., van der Pol S.M., Leyen T., van Het Hof B., Couraud P.O., Vivien D., Dijkstra C.D., de Vries H.E. Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier. J. Immunol. 2008, 181:3567-3574.
38. Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., Noda T., Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol. Biol. Cell 2000, 11:4131-4142.
39. Scott G.S., Hake P., Kean R.B., Virag L., Szabo C., Hooper D.C. Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis. J. Neuroimmunol. 2001, 117:78-86.
40. Song F., Wardrop R.M., Gienapp I.E., Stuckman S.S., Meyer A.L., Shawler T., Whitacre C.C. The Peyer's patch is a critical immunoregulatory site formucosal tolerance in experimental autoimmune encephalomyelitis (EAE). Autoimmun. 2008 Jun, 30(4):230-237.
41. Sozen T., Tsuchiyama R., Hasegawa Y., Suzuki H., Jadhav V., Nishizawa S., Zhang J.H. Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke 2009, 40:2519-2525.
42. Stockinger B., Veldhoen M. Differentiation and function of Th17 T cells. Curr. Opin. Immunol. 2007, 19:281-286.
43. Sun X., Minohara M., Kikuchi H., Ishizu T., Tanaka M., Piao H., Osoegawa M., Ohyagi Y., Shimokawa H., Kira J. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2006, 180:126-134.
44. Tachibana E., Harada T., Shibuya M., Saito K., Takayasu M., Suzuki Y., Yoshida J. Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage. Acta Neurochir. 1999, 141:13-19.
45. Van Itallie C.M., Anderson J.M. The role of claudins in determining paracellular charge selectivity. Proc. Am. Thorac. Soc. 2004, 1:38-41.
46. Vorbrodt A.W., Dobrogowska D.H. Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view. Brain Res. Brain Res. Rev. 2003, 42:221-242.
47. Walsh S.V., Hopkins A.M., Chen J., Narumiya S., Parkos C.A., Nusrat A. Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarized intestinal epithelia. Gastroenterology 2001, 121:566-579.
48. Wong V., Gumbiner B.M. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J. Cell Biol. 1997, 136:399-409.
49. Wosik K., Cayrol R., Dodelet-Devillers A., Berthelet F., Bernard M., Moumdjian R., Bouthillier A., Reudelhuber T.L., Prat A. Angiotensin II controls occluding function and is required for blood-brain barrier maintenance: relevance to multiple sclerosis. J. Neurosci. 2007, 27:9032-9042.
50. Yamamoto M., Ramirez S.H., Sato S., Kiyota T., Cerny R.L., Kaibuchi K., Persidsky Y., Ikezu T. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. Am. J. Pathol. 2008, 172:521-533.
51. Yang Y., Estrada E.Y., Thompson J.F., Liu W., Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 2007, 27:697-709.
52. Yang F.Y., Horng S.C., Lin Y.S., Kao Y.H. Association between contrast-enhanced MR images and blood-brain barrier disruption following transcranial focused ultrasound. J. Magn. Reson. Imaging 2010, 32:593-599.
53. Yu J.Z., Ding J., Ma C.G., Sun C.H., Sun Y.F., Lu C.Z., Xiao B.G. Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor. J. Neurosci. Res. 2010, 88:1664-1672.
54. Zhang Z., Schittenhelm J., Meyermann R., Schluesener H.J. Lesional accumulation of RhoA(1) cells in brains of experimental autoimmune encephalomyelitis and multiple sclerosis. Neuropathol. Appl. Neurobiol. 2008, 34:231-240.
55. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative. Disord. Neuron 2008, 57:178-201.